WATCH THE COLLOQUIUM VIDEOS
VIDEO PRESENTATION OF LORIA
ORPHAMINE: A TOOL TO LEARN MORE ABOUT RARE DISEASES
SYLVAIN LEFEBVRE IS AWARDED AN ERC GRANT
The collaborative project between the Loria (University of Lorraine, Inria and CNRS) and the JAIST (Japan Advanced Institute of Science and Technology) based in Kanazawa (Japan) was made official on Thursday November 3rd at 6 p.m. at
A team of researchers, Joshua Fried and Nancy Nadia Heninger (University of Pennsylvania), Pierrick Gaudry (CNRS/University of Lorraine) and Emmanuel Thomé (CARAMBA team, Inria/University of Lorraine), has recently demonstrated that certain standards used in cryptography in order to secure exchanges and communication use prime numbers whose origin is unverifiable: at least 37% in HTTPS (of the million most visited Internet websites), and at least 13% on IPsec VPNs. This represents a real risk of spying on both individuals and economic interests.
Like Dr. House in the series of the same name, doctors sometimes come up against enigmas when faced with certain pathologies. The aim of the OrphaMine platform developed as part of the ANR Hybride project is to increase specialists’ understanding of rare diseases. The platform has been tested in-house and will soon be offered to a broader panel made up of doctors, researchers and representatives of the pharmaceutical industry.
In the framework of the French Investissements d’Avenir (Investments For The Future) programme, the French government is supporting the OpenPaas::NG project with 10.7M€ of funding. This project, also funded by Bpifrance and led by Linagora, is run in partnership with the Coast team for the research segment, its aim being to provide a complete new generation virtual office solution for companies and public administration offices.